Hypertensive Disorders of Pregnancy
Hypertensive Disorders of Pregnancy
Hypertensive Disorders of Pregnancy
of Pregnancy
Learning Objectives
Define chronic hypertension of pregnancy
Define preeclampsia and eclampsia
Discuss the etiologies of and risk factors for
hypertensive disorders of pregnancy
Review the clinical management of
hypertensive disorders of pregnancy
Definitions
Chronic hypertension in pregnancy
Mild – SBP>=140mmHg, DBP>=90mmHg
Severe – SBP>=180, DBP>=110
Using antihypertensives before pregnancy
Onset before 20 weeks EGA
Persistence beyond postpartum period (12
weeks)
Preeclampsia
A clinical diagnosis defined by a classic triad:
Hypertension (BP ≥ 140/90)
Proteinuria (1+ dipstick or 300 mg/24 hr)
Edema (especially non-dependent)]
No longer considered a required component
Mild preeclampsia meets the above criteria
Severe Preeclampsia
Any one of the following:
Blood pressure sustained above 160/110
Proteinuria >2+ dipstick or > 5 gm/24 hr
Headache/visual disturbances
Epigastric pain
Oliguria (< 500 mL/24 hours)
HELLP syndrome
Fetal growth restriction
Eclampsia
Seizure activity unrelated to other central
nervous system disorders (epilepsy,
meningitis, mass lesion, intracranial
hemorrhage), with or without resultant
coma
Associated with ~50,000 maternal deaths
(10% of total) worldwide each year
Incidence
12 – 22% pregnancies – affected by hypertensive
diseases during pregnancy
5% - chronic hypertension in pregnancy.
5-8% - preeclampsia, 10% of whom develop
eclampsia
Hypertensive diseases - responsible for 17.6% of
maternal deaths in the US. In 2003, there were 495
pregnancy-associated deaths, 68 (14%) due to
hypertension.
Risk Factors
Nulliparity
Previous pregnancy with preeclampsia
Family history of preeclampsia
Chronic hypertension (30%)
Diabetes mellitus (30-50%)
Risk Factors
Renal disease (30-50%)
Multiple gestation
Hydatidiform mole
Age > 35
Pathophysiology
Incompletely understood
Thought to stem from inadequate invasion of
trophoblast into the myometrium
This lack of invasion allows the myometrial
portion of the spiral arterioles to maintain
their muscular walls, preventing
development of the normal low-resistance
uteroplacental circulation.
Pathophysiology
Increased vascular reactivity
Increased platelet activation
Altered prostanoid balance favoring
production of TXA2 and PGF2
(vasoconstrictors, platelet aggregators) over
PGI2 and PGE (vasodilators, platelet dis-
aggregators).
Pathophysiologic manifestations
Alterations are seen in nearly every system:
Hematologic
Thrombocytopenia, hemolysis, increased
platelet activation
Cardiovascular
Vasospasm, hemoconcentration
Renal
Proteinuria, oliguria, ATN, acute renal failure
Pathophysiologic manifestations
Hepatic
Elevated transaminases, hyperbilirubinemia,
hepatic hemorrhage
Neurologic
Headache, scotomata, blurred vision,
hyperreflexia, temporary blindness, seizures
Pathophysiologic manifestations
Fetoplacental
IUGR, oligohydramnios, abruption, impaired
gas exchange, nonreassuring fetal status
HELLP Syndrome
Occurs in up to 20% of women with severe
preeclampsia, more commonly in white
women and multigravid women
H-Hemolysis
EL-Elevated liver function tests
AST> 72 IU; LDH > 600 IU
LP-Low platelets
Chronic Hypertension - Evaluation
Specialized testing, ideally prior to
pregnancy (ECHO, ECG, ophthlalmologic
exam, renal sonography)
Rule out other medical etiologies
(pheochromocytoma, Cushing’s syndrome)
Chronic Hypertension -
Management
Generally, deliver at term, unless
superimposed preeclampsia, HELLP
syndrome
Avoid ACE inhibitors (renal failure,
oligohydramnios, pulmonary hypoplasia,
IUGR) and atenolol (IUGR)
Preeclampsia-Management
Seizure prophylaxis
Blood pressure control
Delivery
Preeclampsia-Term Pregnancy
Delivery is a short-term goal
Induction of labor is appropriate after
maternal-fetal observation/stabilization
Cesarean reserved for standard obstetric
indications
Cesarean may be recommended in cases of
severe preeclampsia where delivery is remote
Preeclampsia-Preterm Pregnancy
Expectant management of severe
preeclampsia at preterm gestational age:
Hospitalization
Magnesium sulfate for seizure prophylaxis, at
least during initial observation period
Blood pressure control to range of 140-155/90-
105 (labetalol or nifedipine)
Daily assessment of maternal-fetal condition
Preeclampsia-Preterm Pregnancy
24-34 weeks – corticosteroids for fetal lung
maturation
24-32 weeks – ongoing daily surveillance if
stable
33-34 weeks – deliver after 48 hours
Deliver for HELLP syndrome, severe
headache, uncontrolled hypertension,
eclampsia
Magnesium Sulfate
Magnesium as the primary agent in the
treatment of eclampsia and suggested its use
for the prevention of eclampsia
Has a direct vascular relaxant effect, but is
NOT an antihypertensive agent
Magnesium Sulfate
Given IV (most commonly) or IM
6 gram load followed by 2 grams per hour
Therapeutic range 6-8 mg/dL
Supratherapeutic levels lead to CNS
depression, cardiac arrythmias, possible
cardiac arrest (Mg level 15-20 mg/dL)
Antidote - Calcium gluconate
Magnesium Sulfate
Continued until about 24 hours post-partum,
depending on the patient’s condition
While some argue the use of magnesium in
mild preeclampsia, most authorities
advocate its use in all women with
preeclampsia
Antihypertensive Agents
Labetalol - alpha-1/beta blocker
Hydralazine - direct arteriolar relaxation
Nifedipine - calcium channel blockade
should be used with caution due to
synergistic hypotensive and negative
inotropic effect with MgSO4
Sodium nitroprusside - severe hypertension
Antihypertensive Agents
AVOID:
Alpha-methyldopa - works too slowly
ACE-inhibitors - fetal renal failure with
chronic use, not studied for acute use
Diuretics - decrease uterine perfusion
Calcium channel blockers (some would say)
Eclampsia
Typical seizure lasts 75-90 seconds with 2
phases: 15-30 seconds of facial twitching
progressing to generalized rigidity, then
about 60 seconds of tonic-clonic activity
Segmental constriction and dilatation of
cortical arterioles leads to decreased
perfusion and cerebral edema
Reduced breathing, fetal bradycardia occur
Eclampsia - Treatment
1. Protect airway
2. Position in left lateral decubitus (prevent
aspiration, aid uterine perfusion)
3. Prevent injury
4. Oxygen
5. Magnesium sulfate (after seizure has
terminated)
Preeclampsia - Recurrence
Increased risk of recurrence in future
pregnancies (especially early onset or
severe) – up to 30-45%
Increased lifetime risk of chronic
hypertension
Increased risk of preeclampsia for the
patient’s sisters and daughters
Case 1
18 yo G1, 37 weeks EGA presents to office
with headache, seeing spots. Gained 5 lbs in
past week. BP 140/90, 2+ protein in urine.
Case 1
Appropriate tests include all except:
24 hour urine collection
liver enzymes, platelet count
repeat blood pressure measurement
fetal monitoring
cord blood gases
Case 1
You decide to admit the patient, as her
repeat blood pressure and other laboratory
results indicate mild preeclampsia. While
on the elevator down to the 2nd floor for
your fourth Cesarean delivery, you get
paged to see the patient because the family
thinks she had a seizure. You arrive to see
tonic-clonic activity.
Case 1
The most appropriate next step is to:
leave the patient downstairs to do an immediate
Cesarean
quickly do the original Cesarean so you can attend to
the seizing patient
assess maternal status, assess fetal status
give Magnesium Sulfate
wake up the chief and ask her what she would like in
her coffee before you ask her what to do, as you both
are likely to be up for a while
Sources
2007 Compendium
Williams Obstetrics
Preeclampsia/Eclampsia presentation by C.
Chisholm, M.D.